Manufacturers of vaginal contraceptives "encouraged" to evaluate STD prevention.
This article was originally published in The Tan Sheet
Executive Summary
OTC VAGINAL CONTRACEPTIVE MANUFACTURERS "ENCOURAGED" TO EVALUATE STD (sexually transmitted disease) prevention in the Feb. 3 tentative final monograph on the product class. The TFM states that FDA "strongly encourages manufacturers to evaluate these products for use in the prevention of infectious diseases" because the "identification of safe and effective products to prevent the transmission of HIV and other STDs is a high-priority health concern."